2025 Dicey Scroggins Distinguished Advocate Award

2025 Dicey Scroggins Distinguished Advocate Award
This award recognizes advocates and organizations that provide active, dedicated service to patients/survivors, families, and caregivers—on a local, regional, or international level—and persistently engage in the fight against gynecologic cancers. 

Eva-Maria Strömsholm (Finland) has been selected as one of three recipients of the 2025 Dicey Scroggins Distinguished Advocate Award, in recognition of her extraordinary commitment to gynecologic cancer advocacy and patient-centered care. 

A survivor of dysgerminoma, a rare ovarian cancer diagnosed at just 27, Eva-Maria has transformed her personal experience into a lifelong mission to improve outcomes for women affected by gynecologic cancers—particularly those facing rare diagnoses. Her resilience and unwavering positivity have inspired patients, clinicians, and advocates around the world. 

Eva-Maria brings both professional and personal insight to her advocacy, drawing on her experience as a nurse to inform her compassionate and practical approach. She actively collaborates with major international organizations, including the European Society of Gynaecological Oncology (ESGO/ENGAGe), the European Society of Medical Oncology (ESMO), the World Ovarian Cancer Coalition (WOCC), ERN EURACAN, WHO/IARC, and IGCS, among others. 

Among her many contributions, Eva-Maria has played a key role in: 

• Co-founding the Finnish Association of Gynaecological Cancer Patients 

• Developing patient information leaflets for rare gynecologic cancers, now published by EURACAN. 

• Advancing the “Diagnosis Curator” model to support patients shortly after diagnosis. 

• Serving on numerous global working groups to improve cancer care and patient inclusion in research and policymaking. 

She is also Chair of the Nordic Gynecological Cancer Patient Organisation Network (NGPO) and a respected voice for patients across Europe and beyond. In her home country of Finland, the jury of the Citizen’s Forum honored her with the title, “Volunteer of the Year” in 2022 for her voluntary work in the cancer field and for cancer patients. 

Eva-Maria exemplifies the spirit of this award through her passion, leadership, and tireless efforts to ensure that all gynecologic cancer patients—no matter how rare their diagnosis—are heard, supported, and empowered. 

2025 Dicey Scroggins Distinguished Advocate Award
This award recognizes advocates and organizations that provide active, dedicated service to patients/survivors, families, and caregivers—on a local, regional, or international level—and persistently engage in the fight against gynecologic cancers.

Nefa-Tari Moore
United States

The International Gynecologic Cancer Society is proud to announce that Nefa-Tari Moore, Director of Black Women’s Outreach at SHARE Cancer Support, has been selected as one of three recipients of the 2025 Dicey Scroggins Distinguished Advocate Award.

A three-time uterine and ovarian cancer thriver, Licensed Practical Nurse, and tireless patient advocate, Ms. Moore has transformed her personal journey into a mission of empowerment, awareness, and systemic change. After finding hope and solidarity through a SHARE support group, she became an AfroSHARE Ambassador and later played a pivotal role in launching SHARE’s national Uterine Cancer Program—designed to center and support the voices of Black women, who are disproportionately affected by uterine cancer.

With a healthcare background and a lifelong commitment to community activism, Ms. Moore now leads impactful programs that educate, uplift, and connect people affected by gynecologic cancers. She has facilitated transformative peer-led groups and continues to amplify survivor perspectives through high-profile initiatives, including the Spot Her campaign and the first-ever AfroSHARE Summit held in June this year.

A nationally recognized patient expert and speaker, Ms. Moore has served on the National Cancer Institute’s Uterine Cancer Task Force and collaborates with major healthcare institutions and oncology forums worldwide to drive policy change and improve equity in cancer care.

With grace, empathy, and unwavering purpose, Nefa-Tari Moore exemplifies the legacy of Dicey Scroggins—bridging personal experience with public impact. Please join us in celebrating her achievements and the extraordinary contributions she continues to make to the gynecologic cancer community.

2025 Dicey Scroggins Distinguished Advocate Award
This award recognizes advocates and organizations that provide active, dedicated service to patients/survivors, families, and caregivers—on a local, regional, or international level—and persistently engage in the fight against gynecologic cancers.

The Irish Society of Gynaecological Oncology Public and Patient Involvement Group (ISGOPPI)
Ireland

The International Gynecologic Cancer Society is honored to announce that the Irish Society of Gynaecological Oncology Public and Patient Involvement group (ISGOPPI) has been selected as one of three recipients of the 2025 Dicey Scroggins Distinguished Advocate Award.

Led by visionary co-founders Dr. Sharon O’Toole and Yvonne O’Meara, ISGOPPI has become Ireland’s national leader in centering the patient voice within gynecologic cancer care, education, and research. The group operates under the umbrella of the Irish Society of Gynaecological Oncology (ISGO), a multidisciplinary society encompassing all gynecologic cancers. ISGOPPI has forged a strong, collaborative model for public and patient involvement that is transforming how ovarian, cervical, uterine, vaginal, and vulvar cancers are understood, experienced, and addressed.

Through groundbreaking initiatives such as the personalised platform thisisGO.ie, the collaborative OvaCare support and networking program, and nationwide awareness campaigns, ISGOPPI has built a powerful community of advocates, researchers, and survivors. Since its founding in 2016, the group has trained more than 100 patient partners in research methods, enabling true co-production of national policy, public education, and scientific discovery. Their work has contributed to earlier detection, better survivorship, and greater empowerment for women across Ireland and beyond.

ISGOPPI’s success is rooted in the passion and generosity of its members, their willingness to share their stories and expertise, and the dedication of healthcare professionals committed to improving outcomes through partnership. The legacy of this group—and of Sharon and Yvonne’s leadership—is perhaps best measured in the lives they’ve touched: from individual patients finding community and strength, to national health systems shaped by survivor voices, to international collaborations inspired by their inclusive approach.

Through compassion, collaboration, and a commitment to equity, ISGOPPI truly embodies the spirit of Dicey Scroggins. We are proud to recognize their extraordinary contributions to gynecologic cancer advocacy.